Prevalence of Renal Failure and Risk Factors in an Unreferred Healthy Population
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00365911|
Recruitment Status : Completed
First Posted : August 18, 2006
Last Update Posted : June 2, 2011
Blood sample is taken for measurement of serum creatinine, cystatin C, clone V haemoglobin, cholesterol, urine acid, glycemia and CRP.
The medical file is gathered. There will be searched for an association between renal function and cardiovascular risk factors and risk factors by exposition to toxic substantia during work.
|Condition or disease||Intervention/treatment||Phase|
|Healthy||Procedure: Taking blood sample||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||2000 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Prevalence of Renal Failure and Risk Factors in an Unreferred Healthy Population|
|Study Start Date :||March 2006|
|Actual Primary Completion Date :||December 2009|
|Actual Study Completion Date :||December 2009|
- Procedure: Taking blood sample
A blood sample will be taken.
- A possible association between renal clearance and found cardiovascular risk factors and risk factors by exposition to toxic substantia during work. [ Time Frame: At time T0 ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00365911
|University Hospital Ghent|
|Ghent, Belgium, 9000|
|Principal Investigator:||Raymond Vanholder, MD, PhD||University Hospital, Ghent|
|Principal Investigator:||Wim Van Biesen, MD, PhD||University Hospital, Ghent|